The Science Behind Mounjaro: Dual GIP and GLP-1 Receptor Agonist Explained
Mounjaro (generic name tirzepatide) is an innovative medication that has gained attention for its role in improving blood sugar control and promoting weight loss in people with type 2 diabetes. What makes Mounjaro unique is that it is the first medication to act as a dual GIP and GLP-1 receptor agonist